Remepy Remepy Raises $36 Million Series A to Expand Its Hybrid Drug™ Pipeline Through Pharmaceutical Partnerships and Advance Phase III of Hybridopa™ for Parkinson’s Disease yahoo!finance 2026.08.12
Remepy Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s DRUG DISCOVERY & DEVELOPMENT 2026.06.08
